Engineering a Smart Agent for Enhanced Immunotherapy Effect by Simultaneously Blocking PD‐L1 and CTLA‐4

Combinations of immune checkpoint therapies show encouraging results in the treatment of many human cancers. However, the higher costs and greater side effects of such combinations compared with single‐agent immunotherapies limit their further applications. In this work, a novel smart agent, KN046@(...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Chunjuan, Zhang, Le, Xu, Xiaoping, Qi, Ming, Zhang, Jianping, He, Simin, Tian, Qiwei, Song, Shaoli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529437/
https://www.ncbi.nlm.nih.gov/pubmed/34473430
http://dx.doi.org/10.1002/advs.202102500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529437/
https://www.ncbi.nlm.nih.gov/pubmed/34473430
http://dx.doi.org/10.1002/advs.202102500

Ejemplares similares